The validated UCB acquisition strategy for Bayesian drug optimization can be extended to AI agent tool selection, where exploration bonuses prevent premature convergence to suboptimal tool schemas in multi-agent workflows.

This discovery has a Claude-generated validation package with a full experimental design.

Precise Hypothesis

Spine & Adversarial ReadReady for validation

“This hypothesis tests whether a UCB-style exploration bonus, transferred from Bayesian drug-target candidate selection, measurably reduces premature convergence to suboptimal tools in multi-agent LLM workflows compared to greedy and epsilon-greedy baselines.”

• highThe analogy between 'drug target candidate selection' and 'LLM tool selection' is superficial — UCB is a generic bandit algorithm with decades of application across domains, so showing it works for tool selection is not a transfer of the MS-specific finding, just a re-application of textbook UCB. The MS discovery contributes no special validation to this claim.
  Acknowledged gap: this EVP does not establish that anything specific to the MS target-discovery UCB implementation (e.g., its composite scoring weights, GP kernel choices) transfers — only that the general UCB family does. The EVP should be framed as testing the generic bandit-exploration hypothesis in a new domain, not as validating a domain-specific transfer; novelty claim should be narrowed accordingly in any write-up.
• highWhy these particular methods (UCB1/GP-UCB, ToolBench/API-Bank, LangGraph/AutoGen) and not alternatives like Thompson sampling, contextual bandits with LinUCB, or RL-based tool routing (PPO-trained routers)? The methodology section does not justify why bandit-style exploration is the right comparison class versus established RL or reflection-based agent self-correction methods already in the literature.
  Partial resolution: UCB/GP-UCB chosen for direct lineage to the cited drug-optimization methodology (same acquisition function family), enabling a clean 'same algorithm, new domain' test rather than introducing confounds from switching algorithm class. However, the EVP explicitly adds a reflection-based baseline (Reflexion-style) as a comparison arm to address the RL/self-correction alternative; Thompson sampling and LinUCB are left as follow-up ablations, not covered in this minimum viable test — this is an acknowledged scope limitation, not a resolved gap.
• medium500 episodes per policy/domain/backend may be underpowered to detect a 15% relative effect size with paired bootstrap at p<0.05, especially given high variance in LLM-judged rewards; the power analysis is not shown.
  Gap: no formal power calculation is provided in this EVP. Must run a pilot-based power analysis (using pilot variance estimates from the 50-episode pilot) before committing to the full 9,000-episode run; the ABORT_CHECKPOINTS partially mitigate this by allowing early termination, but sample size justification should be added before pre-registration.

Experimental Protocol

ROI Projection

Implementation Sketch

class UCBToolSelector:
    def __init__(self, tools, beta=1.0):
        self.n = {t: 0 for t in tools}
        self.mean_reward = {t: 0.0 for t in tools}
        self.t = 0
        self.beta = beta

    def select(self):
        self.t += 1
        unexplored = [t for t in self.n if self.n[t] == 0]
        if unexplored:
            return unexplored[0]
        scores = {
            t: self.mean_reward[t] + self.beta * sqrt(log(self.t) / self.n[t])
            for t in self.n
        }
        return max(scores, key=scores.get)

    def update(self, tool, reward):
        self.n[tool] += 1
        self.mean_reward[tool] += (reward - self.mean_reward[tool]) / self.n[tool]

# Orchestrator loop
for episode in range(N_EPISODES):
    selector = UCBToolSelector(tool_set, beta=tuned_beta)
    for step in range(MAX_STEPS):
        tool = selector.select()
        result, reward = agent.invoke_tool(tool, context)
        selector.update(tool, reward)
    log_episode_metrics(episode, selector)